Abstract Transgender individuals represent 0.55% of the US population, equivalent to 1.4
million transgender adults. In transgender women, feminisation can include a number of …

Objective To review of the existing literature, current guidelines and standard of practice
related to prostate cancer in transgender women, as the transgender population share many …

Introduction As the transgender patient population continues to increase, urologists and
other providers who treat genitourinary malignancies will increasingly encounter cases of …

Abstract Purpose of Review To systematically review the evidence on prostate cancer (PCa)
in transgender women (TGW). Recent Findings A total of 25 studies were included. Fourteen …

Objective To critically analyze the available evidence regarding the incidence,
etiopathogenesis, and management of prostate cancer (CaP) in transgender women. In …

Abstract Male-to-female (MtF) transgender individuals are at risk for prostate cancer,
although guidelines for screening and management in this population are not well …

Transgender women, who were assigned male at birth but identify as women, may take
several steps to merge their physical and psychological identities, including gender …

The incidence of prostate cancer in transsexual patients is very low with only few reported
cases. Many years before presenting with prostate cancer, these patients receive hormone …

Abstract Context Approximately 0.4–1.3% of the worldwide population is transgender.
Although the exact prevalence is unknown, there is an increase in open identification as …

BACKGROUND Prostate adenocarcinoma (PCa) is a rare diagnosis in the male to female
transgender (MtFT) population with only a few case reports published in the current medical …